WANBURY
Back to All Ratios
|
WANBURY Last 5 Year Return on Equity (ROE) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
ROE(%) | - | - | - | - | - |
What is the latest Return on Equity (ROE) ratio of WANBURY ?
Year | Return on Equity (ROE) |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2021 | - |
Mar2020 | - |
How is Return on Equity (ROE) of WANBURY Trending?
Years | Return on Equity (ROE) | % Change | |
---|---|---|---|
Mar2024 | 0 | 0 | |
Mar2023 | 0 | 0 | |
Mar2022 | 0 | 0 | |
Mar2021 | 0 | 0 | |
Mar2020 | 0 | - |
Other Financial Ratios of WANBURY
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Equity (ROE) ratio of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹920.5 Cr | -7.3% | 11.3% | 16% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,408.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -7.3% |
11.3% |
16% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses